logo
Plus   Neg
Share
Email

Nvidia Q3 Revenue Miss, Outlook Weak; Shares Down 16%

Shares of Nvidia Corp. (NVDA) plunged 16% in extended session on Thursday after chip designer's third-quarter revenues and fourth quarter outlook fell short of Wall Street estimates.

Santa Clara, California-based Nvidia's third-quarter profit surged to $1.23 billion or $1.97 per share from $838 million or $1.33 per share last year.

Adjusted earnings for the quarter increased to $1.15 billion or $1.84 per share from $833 million or $1.33 per share last year. On average, 20 analysts estimated earnings of $1.71 per share for the quarter.

Nvidia's revenues for the quarter jumped 21 percent to $3.18 billion from $2.64 billion last year. Analysts had a consensus revenue estimate of $3.24 billion for the quarter.

Nvidia's gross margin for the quarter improved to 60.4 percent from 59.5 percent last year.

Looking forward to the fourth quarter, the company expects revenues of $2.70 billion, plus or minus two percent. Analysts currently estimate revenues of $3.40 billion for the quarter.

NVDA closed Thursday's trading at $202.39, up $5.20 or 2.64%, on the Nasdaq. The stock, however, slipped $32.12 or 15.87% in the after-hours trade.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Microsoft has delayed the worldwide launch of its Surface Earbuds till Spring 2020. The $249 wireless earbuds were originally expected to launch this year. The delay is a setback in Microsoft's attempt to compete with Apple's latest earbuds, AirPods Pro, which has a new design and features active noise cancellation. General Motors Co. (GM) is hiring for new workforce, after cutting about some 4,000 salaried employees early this year. According to Detroit Free Press, the auto giant is hiring for a new workforce as the company invests more money to develop electric and self-driving vehicles. Earlier this year,... Australia's Federal Court has ruled in favor of more than 1,000 women in a landmark class-action lawsuit against Johnson & Johnson after they suffered severe pain and complications from the healthcare giant's pelvic mesh implants. Johnson & Johnson and its subsidiary Ethicon were accused of hiding the risks of its pelvic mesh products.
Follow RTT
>